World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
43854
World Ranking
9910
National Ranking
5098

Dennis C. Sgroi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dennis C. Sgroi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 267 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dennis C. Sgroi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dennis C. Sgroi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dennis C. Sgroi is affiliated with Harvard University in the United States. Their research spans multiple interconnected fields, primarily within biochemistry, genetics, molecular biology, and medicine, with a strong focus on cancer-related studies.

The main fields of study for Dennis C. Sgroi include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Their subfields of study reflect specialized areas of cancer and medical research:

  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Genetics
  • Oncology
  • Pathology and Forensic Medicine

Dennis C. Sgroi's research covers several key topics, emphasizing cancer treatment and molecular diagnostics:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics
  • Estrogen and related hormone effects
  • Genetic factors in colorectal cancer
  • Breast Lesions and Carcinomas
  • Cancer-related Molecular Pathways

The scientist has contributed to recent publications, with a focus on cancer biology and therapeutic response. Notable papers include:

  • A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns, 2020, Nature Communications
  • Sex differences in oncogenic mutational processes, 2020, Nature Communications
  • CD8 + T cell immunity blocks the metastasis of carcinogen-exposed breast cancer, 2021, Science Advances
  • Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study, 2022, Clinical Cancer Research
  • Breast Cancer Index (BCI) and prediction of benefit from extended aromatase inhibitor (AI) therapy (tx) in HR+ breast cancer: NRG oncology/NSABP B-42., 2021, Journal of Clinical Oncology

Frequent co-authors collaborating with Dennis C. Sgroi include:

  • Catherine A. Schnabel
  • Kai Treuner
  • Gurnit Atwal
  • Fátima Al-Shahrour
  • Esther Rheinbay

The primary venues where Dennis C. Sgroi frequently publishes are:

  • Cancer Research
  • Clinical Cancer Research
  • Nature Communications
  • UNC Libraries
  • Journal of Clinical Oncology

Best Publications

  • Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

    Akira Orimo;Piyush B. Gupta;Dennis C. Sgroi;Fernando Arenzana-Seisdedos

  • Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

    Min Yu;Aditya Bardia;Ben S. Wittner;Shannon L. Stott

  • Sequence analysis of mutations and translocations across breast cancer subtypes

    Shantanu Banerji;Kristian Cibulskis;Claudia Rangel-Escareno;Kristin K. Brown

  • Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

    Daniel P. Silver;Andrea L. Richardson;Aron C. Eklund;Zhigang C. Wang

  • A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

    Xiao Jun Ma;Zuncai Wang;Paula D. Ryan;Steven J. Isakoff

  • Gene expression profiles of human breast cancer progression

    Xiao-Jun Ma;Ranelle Salunga;J. Todd Tuggle;Justin Gaudet

  • Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

    Michael Overholtzer;Jianmin Zhang;Gromoslaw A. Smolen;Beth Muir

  • Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

    Min Yu;Min Yu;Aditya Bardia;Nicola Aceto;Francesca Bersani

  • Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification.

    Morgan L. Maeder;Stacey Thibodeau-Beganny;Anna Osiak;David A. Wright

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

    Daphne W. Bell;Thomas J. Lynch;Sara M. Haserlat;Patricia L. Harris

  • Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.

    Maurice Phillip DeYoung;Peter Horak;Avi Sofer;Dennis Sgroi

  • Gene expression profiling of the tumor microenvironment during breast cancer progression

    Xiao-Jun Ma;Sonika Dahiya;Elizabeth A Richardson;Mark G. Erlander

  • Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

    Gromoslaw A. Smolen;Raffaella Sordella;Beth Muir;Gayatry Mohapatra

  • Planning cancer control in Latin America and the Caribbean

    Paul E. Goss;Brittany L. Lee;Brittany L. Lee;Tanja Badovinac-Crnjevic;Kathrin Strasser-Weippl

  • In Vivo Gene Expression Profile Analysis of Human Breast Cancer Progression

    Dennis C. Sgroi;Sarena Teng;Greg Robinson;Rebbecca LeVangie

  • Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor

    Dejan Juric;Pau Castel;Malachi Griffith;Obi L. Griffith

  • The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cells

    Ivan Stamenkovic;Dennis Sgroi;Alejandro Aruffo;Man Sun Sy

  • Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

    Michael G. FitzGerald;Deborah J. MacDonald;Michael Krainer;Ingrid Hoover

  • The molecular pathology of breast cancer progression.

    Alessandro Bombonati;Dennis C Sgroi

Frequent Co-Authors

Daniel A. Haber
Daniel A. Haber Harvard University
Paul E. Goss
Paul E. Goss Harvard University
Sridhar Ramaswamy
Sridhar Ramaswamy Harvard University
Barbara L. Smith
Barbara L. Smith Harvard University
Aditya Bardia
Aditya Bardia Harvard University
Stuart J. Schnitt
Stuart J. Schnitt Brigham and Women's Hospital
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Shyamala Maheswaran
Shyamala Maheswaran Harvard University
Ivan Stamenkovic
Ivan Stamenkovic Harvard University
Susan Bonner-Weir
Susan Bonner-Weir Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare careers beyond a traditional medical degree? There are several accessible and flexible options. For those looking to enter nursing quickly, adn nursing programs offer a streamlined path and often have less competitive entry requirements.

Online pathways are expanding, especially in non-clinical healthcare roles. For example, medical coding and billing classes online with financial aid can lead to fast-growing careers that don’t require patient care experience.

Concerns about entrance exams are common. You may be relieved to learn that some do you have to take the teas test to get into nursing school programs do not require standardized tests like the TEAS or HESI, making the application process less stressful.

If you’re interested in leadership or administrative work in healthcare, a health care administration degree can often be earned online and provides skills for management roles in hospitals, clinics, or insurance companies.

Best Scientists Citing Dennis C. Sgroi

Trending Scientists

Recently Published Articles